Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release, 15-count — NDC 51660-0724-15 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release, 15-count — NDC 51660-724-15 (Billing 51660-0724-15)

by Ohm Laboratories Inc. · 1 BLISTER PACK in 1 CARTON / 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of 15 tablets of Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release from Ohm Laboratories Inc., marketed since Nov 2004 and currently FDA-listed; retail pharmacies pay about $0.5535 per tablet (NADAC). It is the main listing for this product, which comes in 4 package sizes.

NDC 51660-0724-15
🏷️ FDA NDC (as labeled) 51660-724-15 billing pads the product segment with a zero
This package
Contains15-count Cost per ea$0.5535 NADAC Per package$8.30 / 15 tablets Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.8618/unit — full pricing hub ↓
Main listing for product 51660-724 · Also comes in: 5 tablets 51660-724-04 5 tablets 51660-724-56 10 tablets 51660-724-69
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 51660-724-15 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
51660 labeler · 724 product · 15 package
Package marketed since
Nov 17, 2004
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
15 EA per package
Barcode (UPC-A, from the NDC)
3 5166072415 8
Medicaid fills, this package
26,171 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51660-724-15
Product NDC 51660-724
11-digit billing NDC 51660072415
NCPDP billing unit EA — each (per item)
RxCUI 1117562
UNII 7AJO3BO7QN, Y9DL7QPE6B
Application # ANDA076557
SPL Set ID 556b89ef-3b51-4faa-afb4-767a5c1b6422
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2004-11-17
Route ORAL
Dosage form TABLET, EXTENDED RELEASE
Substance LORATADINE; PSEUDOEPHEDRINE SULFATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43993002597520
GPI class Allergy Relief/Nasal Decongest
GCN Seq No 027622
GCN 63577
HICL code 006605
Ingredient (HICL) Loratadine/Pseudoephedrine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2O
Therapeutic class — specific (HIC3) 2Nd Gen Antihistamine And Decongestant Combination
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name ALLERGY RELIEF-NASAL DECONG TB
FDB brand name Allergy Relief-Nasal Decongest
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 027622
  • GCN: 63577
  • GPI-14 (Medi-Span): 43993002597520
  • HICL (First Databank): 006605
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 1117562
Why two NDCs? The FDA registers this code as 51660-724-15 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 51660-0724-15. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ALLERGY RELIEF-NASAL DECONG TB Ingredient Loratadine/Pseudoephedrine
📖 What it is MedlinePlus · NLM

Loratadine is used to treat allergy symptoms: sneezing runny nose itching of the nose or throat red, itchy, or watery eyes Loratadine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves allergy symptoms like sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. It also relieves nasal and sinus congestion from allergie...
  • Swallow the tablet whole with a full glass of water. Never split, crush, chew or dissolve it. Some products are once a day and others are every 12 hours, so check your box and foll...
  • Not if it is an MAOI, or if you stopped one within the last 2 weeks. MAOIs are used for certain depression, psychiatric conditions, and Parkinson's disease. If you are unsure, ask...
  • Taking more than directed may cause drowsiness. Nervousness, dizziness or trouble sleeping can happen too. If any of these occur, stop and talk with your doctor.
📖 Read our full Loratadine / Pseudoephedrine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.554 $8.30 / 15 tablets
Medicaid paysCMS SDUD · 12 mo $0.8618 $12.93 / 15 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.585 $0.506
▲ Up 9% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
51660-0724-04 51660-724-04 3 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.5535 / ea $8.30 2004-11-17 — Active
51660-0724-15 You're viewing this Main listing 1 BLISTER PACK in 1 CARTON / 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.5535 / ea $8.30 2004-11-17 — Active
51660-0724-56 51660-724-56 1 BLISTER PACK in 1 CARTON / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK — — 2004-11-17 — Discontinued by firm
51660-0724-69 51660-724-69 1 BLISTER PACK in 1 CARTON / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK $0.5535 / ea $5.53 2004-11-17 — Active

This pack effectively ties for the lowest per-ea cost of the 3 priced pack sizes ($0.5535 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 96% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 15-count package — 1 blister pack in 1 carton / 15 tablet, extended release in 1 blister pack.
How does this package differ from NDC 51660-0724-56?
Both are Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release — the drug itself is identical. This page's package is the 15-count one, while NDC 51660-0724-56 is the 5 tablets package.
What NDC number is used to bill for this package of Loratadine and Pseudoephedrine 10 mg; 240 mg Tablet, Extended Release?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
allergy d 10 mg/1; 240 mg 00113-9004-22 L. 1 tablet $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 00904-5833-15 Major 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 46122-0167-52 Amerisource 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 46122-0383-22 AMERISOURCE 15 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mgthis 51660-0724-15 Ohm 15 tablets $0.553 — Availability likely —
Leader Allergy Relief D-24 10 mg/1; 240 mg 70000-0162-01 Cardinal 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 70677-1018-01 STRATEGIC 10 tablets $0.553 — Availability likely —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49348-0543-01 STRATEGIC 10 tablets $0.574 — FDA listed +4%
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 62011-0071-01 Strategic 10 tablets $0.574 — FDA listed +4%
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 00363-0725-15 Walgreen 15 tablets — — FDA listed —
Allergy Relief D 10 mg/1; 240 mg 00363-2010-22 Walgreen 1 tablet — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-0102-01 Bayer 10 tablets — — FDA listed —
Claritin-D 24 Hour 10 mg/1; 240 mg 11523-4332-01 Bayer 5 tablets — — Discontinued —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 11822-9990-00 Rite 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 21130-0724-15 Safeway 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 30142-0724-15 The 1 tablet — — FDA listed —
allergy congestion relief 10 mg/1; 240 mg 30142-0846-22 Kroger 1 tablet — — FDA listed —
topcare allergy and congestion relief 10 mg/1; 240 mg 36800-0706-22 Topco 1 tablet — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0427-69 HEB 10 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 37808-0724-69 HEB 10 tablets — — FDA listed —
Allergy Relief-D 240 mg/1; 10 mg 37808-0787-07 HEB 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 41250-0724-52 Meijer 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 49035-0488-15 WAL-MART 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 51660-0491-15 Ohm 15 tablets — — Discontinued —
Loratadine and Pseudoephedrine Sulfate 10 mg/1; 240 mg 56062-0724-15 Publix 15 tablets — — FDA listed —
Allergy Relief-D 10 mg/1; 240 mg 59779-0726-15 CVS 5 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 63187-0305-10 Proficient 10 tablets — — FDA listed —
kirkland signature allerclear d 24 hr 10 mg/1; 240 mg 63981-0138-22 Costco 1 tablet — — FDA listed —
KIRKLAND SIGNATURE ALLERCLEAR D 24 HR Extended Release 10 mg/1; 240 mg 63981-0724-15 Kirkland-COSTCO 15 tablets — — FDA listed —
Loratadine and Pseudoephedrine 10 mg/1; 240 mg 85766-0048-10 Sportpharm 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2004
On the market since
Nov 2004
📍
2026
Currently FDA-listed
22 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
ShapeCapsule
ImprintRX724
Size17 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Loratadine / Pseudoephedrine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H0G9379FGK
    Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
  • UNII XM0M87F357
    A dark iron oxide compound that gives medicines their black or dark color. It's used as a colorant in tablets and capsules to help identify the product and make it visually distinctive.
  • UNII RFW2ET671P
    Hydroxypropyl cellulose is a plant-derived thickening agent made from cellulose. It acts as a binder to hold tablet ingredients together and as a film-former to coat tablets or control how fast the medicine releases.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII 46N107B71O
    Shellac is a natural resin secreted by the lac beetle. It's used as a coating on tablets and capsules to control how quickly the medicine dissolves and to improve appearance and stability.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII C269C4G2ZQ
    Sodium alginate is a natural thickener and gelling agent derived from seaweed. In medicines, it acts as a binder to hold ingredients together, a thickener to adjust texture, and a disintegrant to help the tablet or capsule break apart for absorption.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

17 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCalcium carbonate, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, shellac glaze, sodium alginate, sodium citrate, talc and titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerOhm Laboratories Inc.
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA076557 (ANDA)
Labeler code51660
First marketedNov 2004
Product typeHuman Otc Drug
Portfolio30 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 60 words ▾

USES temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: sneezing itchy, watery eyes runny nose itching of the nose or throat reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 52 words ▾

DIRECTIONS do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet daily with a full glass of water; not more than 1 tablet in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

⚠️ Warnings 196 words ▾

WARNINGS Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease.

Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever. nervousness, dizziness or sleeplessness occurs If pregnant or breast-feeding Ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

🧪 Active Ingredient 14 words ▾

ACTIVE INGREDIENTS (IN EACH TABLET) Loratadine, USP 10 mg Pseudoephedrine sulfate, USP 240 mg

🧪 Inactive Ingredients 36 words ▾

INACTIVE INGREDIENTS Calcium carbonate, colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, pregelatinized starch, propylene glycol, shellac glaze, sodium alginate, sodium citrate, talc and titanium dioxide

🎯 Purpose 4 words ▾

PURPOSE Antihistamine Nasal decongestant

📄 Do Not Use 71 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 38 words ▾

Ask a doctor before use if you have heart disease thyroid disease high blood pressure diabetes trouble urinating due to an enlarged prostate gland liver or kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 17 words ▾

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

📄 Stop Use and Ask a Doctor If 37 words ▾

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever. nervousness, dizziness or sleeplessness occurs

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding Ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 3 words ▾

QUESTIONS? Call 1-800-406-7984

📄 Package Label / Principal Display Panel 97 words ▾

PRINCIPAL DISPLAY PANEL - 15 Tablet Blister Pack Carton † Compare To the active ingredients of Claritin-D ® 24 Hour NDC 51660-724-04 Original Prescription Strength NON-DROWSY* ohm ® Allergy Relief & Nasal Decongestant 24 HOUR Loratadine, USP 10 mg/Antihistamine Pseudoephedrine Sulfate, USP 240 mg/Nasal Decongestant Indoor & Outdoor Allergies Relief of: Nasal & Sinus Congestion Due to Colds or Allergies Sneezing; Runny Nose; Itchy, Watery Eyes; Itchy Throat or Nose Due to Allergies Allergy & Congestion 15 Extended-Release Tablets * When taken as directed.

See Drug Facts Panel. PRINCIPAL DISPLAY PANEL - 15 Tablet Blister Pack Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
26.2K
Units reimbursed last 4 qtrs
729.3K
Gross reimbursed last 4 qtrs
$628.5K
Avg / prescription
$24.02
Avg / unit
$0.8618
Latest quarter Q1 2026
5.1KRx
Medicaid pays / ea
$0.8618
gross reimbursed
vs
NADAC / ea
$0.5535
acquisition cost
=
Spread
+$0.3083
+56% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
85% FFS 15% MCO
Fee-for-service · 22,204 Rx Managed care · 3,967 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 6,448 units · 82.5 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 10,110 units · 176 per 100k residents MN Wisconsin: 12,899 units · 218 per 100k residents WI Michigan: 3,916 units · 39.0 per 100k residents MI New York: 585,768 units · 2,993 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 1,170 units · 27.6 per 100k residents OR Nevada: 1,004 units · 31.4 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 361 units · 2.9 per 100k residents IL Indiana: 1,232 units · 18.0 per 100k residents IN Ohio: 23,579 units · 200 per 100k residents OH Pennsylvania: 16,394 units · 126 per 100k residents PA New Jersey: 15,081 units · 162 per 100k residents NJ Massachusetts: 3,265 units · 46.6 per 100k residents MA California: 1,155 units · 3.0 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 2,344 units · 119 per 100k residents NE Missouri: 11,490 units · 185 per 100k residents MO Kentucky: 22,669 units · 501 per 100k residents KY West Virginia: 2,102 units · 119 per 100k residents WV Virginia: 815 units · 9.4 per 100k residents VA Maryland: 4,869 units · 78.8 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 1,650 units · 22.2 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: 84 units · 0.8 per 100k residents NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: 310 units · 6.8 per 100k residents LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 267 units · 39.3 per 100k residents DC Hawaii: 295 units · 20.6 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.82,993
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 2,993 /100k
2 Kentucky 501 /100k
3 Wisconsin 218 /100k
4 Ohio 200 /100k
5 Missouri 185 /100k
6 Minnesota 176 /100k
7 New Jersey 162 /100k
8 Pennsylvania 126 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
15 tablets this page51660-0724-15 26,171 Rx · $628,523
10 tablets51660-0724-69 1,038 Rx · $22,540
5 tablets51660-0724-04 24 Rx · $660
5 tablets51660-0724-56 No Medicaid data
Drug total (last 4 qtrs): 27,233 Rx · 759,927 units · $651,723 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Loratadine and pseudoephedrine — the ingredient across all brands.

Top reported reactions

Insomnia719
Drug Effect Decreased454
Dizziness376
Somnolence294
Headache283
Nausea279
Fatigue255

Age at onset

Neonate1
Infant4
Child76
Adolescent37
Adult1,062
Elderly621

Reporter sex

7,905 reports
Male · 31%
Female · 69%
Unknown · 0%

Serious outcomes

Hospitalization576
Disabling97
Death88
Life-threatening57
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 312 59
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.